Upon uptake of this nanosystem by EGFR-positive breast cancer cells, endogenous ROS in the tumor region trigger the disassembly of NPs by cleaving thione bonds and releasing doxorubicin (DOX) and Pc molecules. This evidence concerns the gene EGFR and neoplasm.